High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma (Q60339417)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 September 2011

Language	Label	Description	Also known as
English	High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma	scientific article published on 18 September 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

stem cell transplantation

1 reference

based on heuristic

inferred from title

non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Gabriella Serio

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Franca Falzetti

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

Mauro Di Ianni

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

Stelvio Ballanti

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

Giuseppe Iodice

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

Antonia Reale

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

Olivia Minelli

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

Franco Dammacco

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

Angelo Vacca

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

Massimo F Martelli

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

publication date

18 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

Clinical and Experimental Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

165-171

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous tandem transplantation in patients with primary progressive or relapsed/refractory lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose etoposide, thiotepa, and dose-adjusted carboplatin (TVCa) with autologous hematopoietic stem cell rescue as treatment of relapsed or refractory germ cell cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pilot study of tandem high-dose chemotherapy and autologous stem cell transplantation with a novel combination of regimens in patients with poor risk lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin’s lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term survival of patients with resistant lymphoma treated with tandem stem cell transplant

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous bone marrow transplantation in adults with non-Hodgkin's lymphoma: a Southwest Oncology Group study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escalated as Compared with Standard Doses of Doxorubicin in BACOP Therapy for Patients with Non-Hodgkin's Lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel high-dose chemotherapy protocol with autologous hematopoietic rescue in patients with metastatic breast cancer or recurrent non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Outcome following Autologous and Allogeneic Blood and Marrow Transplantation for Relapsed Diffuse Large-Cell Non-Hodgkin’s Lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349).

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphoma rate rise continues to baffle researchers

1 reference

https://pubmed.ncbi.nlm.nih.gov/21928053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10238-011-0157-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21928053 AND SRC:MED&resulttype=core&format=json

12 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q60339417&oldid=2217017897"